Optimal Formula of Angelica sinensis Ameliorates Memory Deficits in β-amyloid Protein-induced Alzheimer’s Disease Rat Model

Abstract

Objective

Angelica (A.) sinensis is used as a traditional medical herb for the treatment of neurodegeneration, aging, and inflammation in Asia. A. sinensis optimal formula (AOF) is the best combination in A. sinensis that has been screened to rescue the cognitive ability in β-amyloid peptide (Aβ_25–35)-treated Alzheimer’s disease (AD) rats. The objective of this study was to investigate the effect of AOF on the learning and memory of AD rats as well as to explore the underlying mechanisms.

Methods

Male Wistar rats were infused with Aβ_25–35 for AD model induction or saline (negative control). Five groups of AD rats were fed on AOF at 20, 40, or 80 mL/kg every day, donepezil at 0.9 mg/kg every day (positive control), or an equal volume of water (AD model) intragastrically once a day for 4 weeks, while the negative control rats were fed on water. The Morris water maze test was used to evaluate the cognitive function of the rats. The Aβ accumulation, cholinergic levels, and antioxidative ability were detected by ELISA. Additionally, the candidate mechanism was determined by gene sequencing and quantitative real-time polymerase chain reaction.

Results

The results showed that AOF administration significantly ameliorated Aβ_25–35-induced memory impairment. AOF decreased the levels of amyloid-β precursor protein and Aβ in the hippocampus, rescued the cholinergic levels, increased the activity of superoxide dismutase, and decreased the malondialdehyde level. In addition, AOF inhibited the expression of IL1b, Mpo, and Prkcg in the hippocampus.

Conclusion

These experimental findings illustrate that AOF prevents the decrease in cognitive function and Aβ deposits in Aβ_25–35-treated rats via modulating neuroinflammation and oxidative stress, thus highlighting a potential therapeutic avenue to promote the co-administration of formulas that act on different nodes to maximize beneficial effects and minimize negative side effects.

Keywords

optimal formula of Angelica sinensis / Alzheimer’s disease / amyloid β aggregation / oxidative stress / neuroinflammation

References

[1] RoyDS, AronsA, MitchellTI, et al.. Memory retrieval by activating engram cells in mouse models of early Alzheimer’s disease. Nature, 2016, 531(7595): 508-512

[2] QuerfurthHW, LaFerlaFM. Alzheimer’s disease. N Engl J Med, 2010, 362: 329-344

[3] YangWN, HanH, HuXD, et al.. The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress. Pharmacol Biochem Behav, 2013, 114: 31-36

[4] OngWY, WuYJ, FarooquiT, et al.. Qi Fu Yin-a Ming Dynasty Prescription for the Treatment of Dementia. Mol Neurobiol, 2018, 55(9): 7389-7400

[5] LuJ, GuoPF, LiuXQ, et al.. Herbal Formula Fo Shou San attenuates Alzheimer’s disease-related pathologies via the gut-liver-brain axis in APP/PS1 mouse model of Alzheimer’s disease. Evid Based Complement Alternat Med, 2019, 2019: 8302950

[6] CaiH, LuoY, YanX, et al.. The mechanisms of bushenyizhi formula as a therapeutic agent against Alzheimer’s disease. Sci Rep, 2018, 8(1): 3104

[7] SunH, HuY, ZhangJM, et al.. Effects of one Chinese herbs on improving cognitive function and memory of Alzheimer’s disease mouse models. Zhongguo Zhong Yao Za Zhi (Chinese), 2003, 28(8): 751-754

[8] FangL, XiaoXF, LiuCX, et al.. Recent advance in studies on Angelica sinensis. Chin Herb Med (Chinese), 2012, 4: 12-25

[9] WeiWL, ZengR, GuCM, et al.. Angelica sisensis in China- A review of botanical profile, ethanopharmacology, phytochemistry and chemical ananylsis. J Ethnopharmacol, 2016, 190: 116-141

[10] WangHP, WuHY, LiHL, et al.. Effects of Angelica Polysaccharide on Learning and Memory Abilities and Aβ Metabolism in Model Rats with Alzheimer Disease. Chin J Informat Tradition Chin Med (Chinese), 2018, 25(4): 51-55

[11] WangHP, WuHY, LiHL, et al.. Compatibility optimization of composing prescription on active components of Danggui (Radix Angelicae senensis) for prevention and cure of Alzheimer’s disease (AD). J Gansu Univ Chin Med (Chinese), 2019, 36(3): 12-19

[12] ZhangY, XiuMM, ZhangQH, et al.. Novokinin inhibits gastric acid secretion and protects against alcohol-induced gastric injury in rats. Alcohol, 2016, 56: 1-8

[13] GongG, QiB, LiangYT, et al.. Danggui Buxue Tang, an ancient Chinese herbal decoction, protects β-amyloid induced cell death in cultured cortical neurons. BMC Complement Altern Med, 2019, 19(1): 9

[14] KanskiJ, AksenovaM, StoyanovaA, et al.. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem, 2002, 13(5): 273-281

[15] ChenD, TangJ, KhatibiNH, et al.. Treatment with Z-ligustilide, a component of Angelica sinensis, reduces brain injury after a subarachnoid hemorrhage in rats. J Pharmacol Exp Ther, 2011, 337(3): 663-672

[16] VassarR, BennettBD, Babu-KhanS. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 1999, 286: 735-741

[17] OsbornLM, KamphuisW, WadmanWJ, et al.. Astrogliosis: An integral player in the pathogenesis of Alzheimer’s disease. Prog Neurobiol, 2016, 144: 121-141

[18] CanterRG, PenneyJ. The road to restoring neural circuits for the treatment of Alzheimer’s disease. Nature, 2016, 539: 187-196

[19] LuC, DongL, LvJ, et al.. 20(S)-protopanaxadiol (PPD) alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of Egr-1, c-Fos and c-Jun in mice. Chem Biol Interact, 2018, 279: 64-72

[20] BallardCG, GreigNH, Guillozet-BongaartsAL, et al.. Cholinesterases: roles in the brain during health and disease. Curr Alzheimer Res, 2005, 2(3): 307-318

[21] YangB, SunX, LashuelH, et al.. Reactive oxidative species enhance amyloid toxicity in APP/PS1 mouse neurons. Neurosci Bull, 2012, 28(3): 233-239

[22] JiangTF, SunQ, ChenSD. Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Prog Neurobiol, 2016, 147: 1-19

[23] MansoH, KrugT, SobralJ, et al.. Variants in the inflammatory IL6 and MPO genes modulate stroke susceptibility through main effects and gene-gene interactions. J Cereb Blood Flow Metab, 2011, 31(8): 1751-1759

[24] ParajuliB, SonobeY, HoriuchiH, et al.. Oligomeric amyloid B induces IL-1b processing via production of ROS: implication in Alzheimer’s disease. Cell Death Dis, 2013, 4: e975

[25] XieLS, LaiY, LeiF, et al.. Exploring the association between interleukin-1β and its interacting proteins in Alzheimer’s disease. Mol Med Rep, 2015, 11(5): 3219-3228

[26] HickmanSE, AllisonEK, El KhouryJ. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice. J Neurosci, 2008, 28(33): 8354-8360

[27] ReynoldsWF, RheesJ, MaciejewskiD, et al.. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp Neurol, 1999, 155(1): 31-41

[28] GreenPS, MendezAJ, JacobJS, et al.. Neuronal expression of myeloperoxidase is increased in Alzheimer’s disease. J Neurochem, 2004, 90(3): 724-733

[29] MakiRA, TyurinVA, LyonRC, et al.. Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease. J Biol Chem, 2009, 284(5): 3158-3169

[30] HulsdunkerJ, ZeiserR. In Vivo Myeloperoxidase Imaging and Flow Cytometry Analysis of Intestinal Myeloid Cells. Methods Mol Biol, 2016, 1422: 161-167

[31] WongMMK, HoekstraSD, VowlesJ, et al.. Neurodegeneration in SCA14 is associated with increased PKCr kinase activity, mislocalization and aggration. Acta Neuropathol Commun, 2018, 6(1): 99